What one share of Curis holds
We are a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule inhibitor of Interleukin-1 receptor associated kinase, or IRAK4 and FMS-like tyrosine kinase 3 or FLT3.
Curis’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $3.70 |
|---|---|
| Profit | −$18.13 |
| Cash and investments | $2.60 |
| Book value | $2.41 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $262.35 | −$300.00 | — | — | — | $1,009 |
| 2010 | $426.89 | −$118.34 | $7.33 | −$50.80 | — | $1,202 |
| 2011 | $386.70 | −$258.25 | $6.82 | −$126.35 | — | $1,034 |
| 2012 | $429.35 | −$415.31 | $2.66 | −$387.01 | — | $856.50 |
| 2013 | $364.39 | −$299.30 | $3.72 | −$235.43 | — | $1,052 |
| 2014 | $228.97 | −$435.69 | $2.14 | −$393.26 | — | $692.38 |
| 2015 | $127.72 | −$956.20 | $0.78 | −$485.37 | — | $1,000 |
| 2016 | $113.37 | −$909.90 | $4.96 | −$544.34 | — | $417.38 |
| 2017 | $132.74 | −$715.02 | $2.52 | −$651.00 | — | $292.32 |
| 2018 | $125.95 | −$393.44 | $1.03 | −$364.15 | — | −$54.24 |
| 2019 | $120.60 | −$387.47 | $0.49 | −$316.40 | — | −$408.05 |
| 2020 | $89.05 | −$245.80 | $5.56 | −$217.10 | — | $571.22 |
| 2022 | $43.52 | −$242.73 | $1.78 | −$234.51 | — | $192.74 |
| 2023 | $37.87 | −$179.14 | $0.00 | −$145.22 | — | $66.74 |
| 2024 | $34.59 | −$137.61 | — | — | — | −$14.13 |
| 2025 | $14.35 | −$11.52 | — | — | — | $8.45 |
Common questions about Curis
How much does one share of Curis earn?
Over the last 12 months, Curis lost $18.13 for each share on $3.70 of sales.
Does Curis pay a dividend?
Curis didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Curis’s book value per share?
Curis’s book value is $2.41 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Curis have?
Each share of Curis has $2.60 of cash and investments, as of June 30, 2026.
Has Curis bought back shares?
Curis’s share count rose about 1910% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.